Provided by Tiger Trade Technology Pte. Ltd.

Goldman Sachs Holdings

2,399.53
+16.750.70%
Number of Gainers:73
Number of Losers:24
Number of Flat:- -
PE:- -
High:2,401.83
Open:2,383.00
Low:2,383.00
Close:2,382.78
Volume:1.13B
Turnover:224.85B
Market Cap:53.18T
Float Cap:49.79T

Loading ...

BlackRock Group Ceases to Be Substantial Shareholder in ALS Ltd

TIPRANKS
·
Oct 01

Google Shows It's not Out of the AI Race Just Yet

Dow Jones
·
Oct 01

Overnight News for October 1: Trump Pressures Powell to Resign Again, Paramount Issues $30 Billion in Bonds, US August Inflation Below Expectations, Goldman Sachs Delays Rate Hike Forecast to December

Deep News
·
Oct 01

Eli Lilly Says Foundayo Drug Helped Patients Lose Weight in Phase 3 Trial

Dow Jones
·
Oct 01

Tech CEOs Privately Questioned Amodei for Sounding AI Alarm Bells

Dow Jones
·
Oct 01

Cvs Health Declares Quarterly Dividend

Reuters
·
Oct 01

Fed Approves Stress Test Overhaul in 6-1 Vote: Capital Requirement Volatility Cut in Half, Lone Dissenter Warns Resilience Weakened

Deep News
·
Oct 01

US Defense Secretary: Musk, Palmer Luckey, and Newt Gingrich to Help Pentagon Advance War Plans

Deep News
·
Oct 01

Analysts Are Bullish on These NA Stocks: Moleculin Biotech (MBRX), Alphabet Class A (GOOGL)

TIPRANKS
·
Oct 01

Eli Lilly’s Foundayo shows cardiovascular safety in type 2 diabetes study

TIPRANKS
·
Oct 01

Lilly's Oral Glp-1, Foundayo (Orforglipron), Demonstrated Cardiovascular Safety Alongside Sustained A1c Reduction and Weight Loss in Its Largest and Longest Type 2 Diabetes Study

THOMSON REUTERS
·
Oct 01

Eli Lilly - Achieve-4: Foundayo Shows 16% Lower Mace-4 and 23% Lower Mace-3 Risk vs Insulin Glargine

THOMSON REUTERS
·
Oct 01

Eli Lilly - Foundayo Shows Smaller Egrf Reduction and Greater Albuminuria Reduction vs Insulin Glargine

THOMSON REUTERS
·
Oct 01

Neptune Insurance Names David Noble Independent Director

Reuters
·
Oct 01

Costco EVP Claudine Adamo Sells 2,200 Shares Worth $2,014,?46**

Reuters
·
Oct 01

NASD Most Active Issues

Dow Jones
·
Oct 01

Trump Says Final US Troops Leaving Iraq Soon, Google Unveils Gemini 4 Argon, Micron Quarterly Revenue Tops $54 Billion

Deep News
·
Oct 01

Exchange Traded Funds Top 10 Volume Leaders

Dow Jones
·
Oct 01

US Stocks: S&P 500 Posts Worst Monthly Performance Since June as Rate Concerns Persist

Deep News
·
Oct 01

U.S. Food and Drug Administration Approves Expanded Indication for Bristol Myers Squibb’s Camzyos® (Mavacamten) for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (Ohcm) in Adults and Pediatric Patients*

THOMSON REUTERS
·
Oct 01